Immuneering Insider Zeskind Updates 3.68M Share Ownership

TL;DR

**Immuneering insider Zeskind still holds over 3.6M shares, showing strong commitment.**

AI Summary

Benjamin J. Zeskind, a key individual at Immuneering Corp, filed an amended SC 13G/A on January 16, 2024, updating his beneficial ownership of Class A Common Stock as of December 31, 2023. He now beneficially owns 3,687,142 shares, comprising 2,792,215 shares with sole voting and dispositive power, and 894,927 shares with shared voting and dispositive power. This filing is important for investors as it clarifies the ownership stake of a significant insider, indicating his continued substantial interest in the company's performance.

Why It Matters

This filing shows that a key insider, Benjamin J. Zeskind, maintains a significant ownership stake in Immuneering Corp, which can signal confidence in the company's future to investors.

Risk Assessment

Risk Level: low — This filing is an update to an existing ownership report and does not indicate any immediate negative or positive financial risk.

Analyst Insight

Investors should note Benjamin J. Zeskind's continued substantial ownership in Immuneering Corp, as it suggests an insider's confidence in the company. While not a direct buy signal, it's a positive indicator of alignment between management and shareholder interests.

Key Numbers

• 2,792,215 — Sole Voting Power Shares (Represents shares Benjamin J. Zeskind can vote and dispose of independently.)
• 894,927 — Shared Voting Power Shares (Represents shares Benjamin J. Zeskind shares voting and dispositive power over.)
• 3,687,142 — Aggregate Shares Beneficially Owned (Total shares Benjamin J. Zeskind has a beneficial interest in, indicating his overall stake.)
• December 31, 2023 — Date of Event (The specific date for which the ownership information is reported.)
• January 16, 2024 — Filing Date (The date the amended SC 13G/A was filed with the SEC.)

Key Players & Entities

• Benjamin J. Zeskind (person) — Reporting Person, key individual at Immuneering Corp
• Immuneering Corp (company) — Issuer of the Class A Common Stock
• 03 Life Sciences (company) — Organization Name associated with the subject company's data
• 2,792,215 (dollar_amount) — shares with sole voting and dispositive power
• 894,927 (dollar_amount) — shares with shared voting and dispositive power
• 3,687,142 (dollar_amount) — aggregate shares beneficially owned

Forward-Looking Statements

• Benjamin J. Zeskind will maintain a significant ownership stake in Immuneering Corp throughout 2024. (Benjamin J. Zeskind) — high confidence, target: December 31, 2024

FAQ

Key Financial Figures

• $0.001 — ities Class A common stock, par value $0.001 per share ("Class A Common Stock"). (

Filing Documents

• zeskind-2024schedule13game.htm (SC 13G/A) — 48KB
• image_5.jpg (GRAPHIC) — 0KB
• 0001870062-24-000005.txt ( ) — 50KB

(a) Name of Issuer

ITEM 1. (a) Name of Issuer Immuneering Corporation (the "Issuer"). (b) Address of Issuer's Principal Executive Offices 245 Main St., Second Floor, Cambridge, MA 02142

(a) Name of Person Filing

ITEM 2. (a) Name of Person Filing This statement is filed on behalf of Benjamin J. Zeskind (the "Reporting Person"). (b) Address or Principal Business Office The principal business address of the Reporting Person is co Immuneering Corporation, 245 Main St., Second Floor, Cambridge, MA 02142. (c) Citizenship of each Reporting Person is The Reporting Person is a citizen of the United States. (d) Title of Class of Securities Class A common stock, par value $0.001 per share ("Class A Common Stock"). (e) CUSIP Number 45254E107 ITEM 3. Not applicable.

Ownership

ITEM 4. Ownership. (a-c) The ownership information presented below represents beneficial ownership of the shares of Class A Common Stock of the Issuer as of December 31, 2023, based upon 29,269,121 shares of Class A Common Stock outstanding as of October 31, 2023, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2023. CUSIP No. 45254E107 Schedule 13G Page 3 of 4 Reporting Person Amount Beneficially owned Percent of class Sole power to vote or to direct the vote Shared power to vote or to direct the vote Sole power to dispose or to direct the disposition of Shared power to dispose or to direct the disposition of Benjamin J. Zeskind 3,687,142 12.6% 2,792,215 894,927 2,792,215 894,927 The Reporting Person is the beneficial owner of 3,687,142 shares of Class A Common Stock, which consist of (i) 2,261,852 shares of Class A Common Stock held of record by the Reporting Person (ii) 530,363 shares of Class A Common Stock underlying stock options held of record by the Reporting Person that are exercisable on or prior to February 29, 2024 and (iii) 894,927 shares of Class A Common Stock held of record by the Benjamin J. Zeskind 2020 Family Trust, of which the Reporting Person's spouse serves as sole trustee.

Ownership of Five Percent or Less of a Class

ITEM 5. Ownership of Five Percent or Less of a Class. Not applicable.

Ownership of More than Five Percent on Behalf of Another Person

ITEM 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. ITEM 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.

Identification and Classification of Members of the Group

ITEM 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

ITEM 9. Notice of Dissolution of Group. Not applicable.

Certification

ITEM 10. Certification. Not applicable. CUSIP No. 45254E107 Schedule 13G Page 4 of 4 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date January 16, 2024 Benjamin J. Zeskind s Benjamin J. Zeskind

View Full Filing

View this SC 13G/A filing on SEC EDGAR